{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:14Z","timestamp":1792787894744,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deputy Research and Affairs of the Bushehr University of Medical Sciences","award":["401-3 and 1401-4"],"award-info":[{"award-number":["401-3 and 1401-4"]}],"id":[{"id":"https:\/\/ror.org\/02y18ts25","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study was designed to determine the seroprevalence of HTLV among multi-transfused patients in the South of Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All patients with\n                      <jats:italic>\u03b2-thalassemia<\/jats:italic>\n                      major and those on regular hemodialysis from the cities of Dashtestan, Bushehr, Genaveh, Tangestan, and Kangan participated in this study. Serum samples were tested for HTLV-I\/II antibodies by ELISA, and Western Blot confirmed seropositive samples. Moreover, hepatitis-related markers were assessed using serological assays.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 134 thalassemia patients, 6 cases (4.48%, 95% CI: 1.83%-9.91%) were positive for HTLV-I\/II antibodies, all of which were confirmed by Western blot as HTLV-1. The hemodialysis patients and the controls were negative for HTLV-I\/II antibodies. Of 6 HTLV-1 seropositive thalassemia patients, 4 cases were positive for anti-HCV antibodies (66.7%), and 2 cases were positive for anti-HEV IgG (33.4%). HTLV-1 seropositive thalassemia patients were negative for HBV infection criteria, while 5 of 6 patients (83.33%) had HBsAb in their samples. HTLV-1 seropositivity increased with age and was higher among single patients, female patients, residents of Kangan, patients receiving blood transfusions every two weeks, and Fars patients. Nevertheless, the seroprevalence of HTLV-1 was not statistically associated with marital status, gender distribution, place of residency, frequency of blood transfusion, age, ethnicity, or level of education.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study reports a relatively high seroprevalence of HTLV-1 among patients with\n                      <jats:italic>\u03b2-thalassemia<\/jats:italic>\n                      major, highlighting a high risk of HTLV-1 exposure in the thalassemia population. Therefore, an evaluation of introducing HTLV donor screening is recommended to reduce the transmission of HTLV-1 infection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-14010-1","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:14:16Z","timestamp":1783930456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of human T-cell lymphotropic virus and transfusion-transmitted viral hepatitis markers among hemodialysis and thalassemia patients in the South of Iran"],"prefix":"10.1186","volume":"26","author":[{"given":"Fatemeh","family":"Farshadpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Avazzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Dehghanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samad","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoun","family":"Vahdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoochehr","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Obeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6499-0531","authenticated-orcid":false,"given":"Reza","family":"Taherkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"1","key":"14010_CR1","first-page":"69","volume":"9","author":"S Mohajeri","year":"2023","unstructured":"Mohajeri S, Khaleghi M, Hassanshahian M, Ravan H, Mirzaei R, Behzadi A, Mohammadhoseini M, Soleimani S, Mohseni M, Dalvand A. Evaluation of prevalence of human t-cell lymphotropic virus in blood donors, thalassemia and hemophilia patients in Rafsanjan and Jiroft cities of Kerman province. Iran J Genet Resour. 2023;9(1):69\u201374.","journal-title":"Iran J Genet Resour"},{"issue":"1","key":"14010_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-024-00656-9","volume":"21","author":"A Letafati","year":"2024","unstructured":"Letafati A, Mozhgani SH, Norouzi M, Aboofazeli A, Taghiabadi Z, Zafarian N, Seyedi S, Jaberi EM, Poursaleh S, Karami M, et al. Declining trend of HTLV-1 among organ\/ tissue donors in Iranian Tissue Bank between 2014\u20132021. Retrovirology. 2024;21(1):22.","journal-title":"Retrovirology"},{"issue":"2","key":"14010_CR3","first-page":"85","volume":"7","author":"M Dayyani","year":"2015","unstructured":"Dayyani M, Hedayati-Moghaddam MR, Amini AR. HTLV-1 infection as a serious health issue among Iranian multi-transfused patients: evidence from a systematic review and meta-analysis. IJBC. 2015;7(2):85\u201394.","journal-title":"IJBC"},{"key":"14010_CR4","unstructured":"World Health Organization. Human T-lymphotropic virus type 1 [Internet]. Geneva: World Health Organization; 2024 Dec [cited 2026 Jul 11]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-t-lymphotropic-virus-type-1."},{"key":"14010_CR5","doi-asserted-by":"crossref","unstructured":"Hedayati-Moghaddam MR, Jafarzadeh Esfehani R, El Hajj H, Bazarbachi A. Updates on the epidemiology of the human T-cell leukemia virus type 1 infection in the countries of the Eastern Mediterranean Regional Office of the World Health Organization with special emphasis on the situation in Iran. Viruses. 2022;14(4).","DOI":"10.3390\/v14040664"},{"issue":"3","key":"14010_CR6","first-page":"187","volume":"7","author":"J Ghaffari","year":"2013","unstructured":"Ghaffari J, Ebrahimi M, Makhlough A, Mohammadjafari H, Nazari Z. Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it? Iran J Kidney Dis. 2013;7(3):187\u201390.","journal-title":"Iran J Kidney Dis"},{"key":"14010_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12882-025-04181-5","volume":"26","author":"M Mohammaditabar","year":"2025","unstructured":"Mohammaditabar M, Forghani-Ramandi MM, Amirani N, Saidi S, Zare S, Fathi Hafshejani N, Mozhgani SH. How serious is the risk of HTLV-1 infection in Iranian hemodialysis-dependent patients? BMC Nephrol. 2025;26:340.","journal-title":"BMC Nephrol"},{"issue":"5","key":"14010_CR8","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.5001\/omj.2022.85","volume":"37","author":"F Farshadpour","year":"2022","unstructured":"Farshadpour F, Taherkhani R. Prevalence and Molecular Evaluation of Hepatitis C Virus Infection among Multi-transfused Thalassemia Patients in South of Iran. Oman Med J. 2022;37(5):e427.","journal-title":"Oman Med J"},{"issue":"2","key":"14010_CR9","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.5001\/omj.2023.60","volume":"38","author":"R Taherkhani","year":"2023","unstructured":"Taherkhani R, Farshadpour F, Asayesh R. Prevalence and Genotypes of Hepatitis C Infection Among Hemodialysis Patients in Bushehr, Iran. Oman Med J. 2023;38(2):e481.","journal-title":"Oman Med J"},{"issue":"2","key":"14010_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/15321819.2022.2163178","volume":"44","author":"F Farshadpour","year":"2023","unstructured":"Farshadpour F, Taherkhani R, Farajzadeh H. Hepatitis B infection among beta-thalassemia major patients in Bushehr province of southern Iran. J Immunoass Immunochem. 2023;44(2):147\u201361.","journal-title":"J Immunoass Immunochem"},{"issue":"5","key":"14010_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4269\/ajtmh.22-0345","volume":"108","author":"F Farshadpour","year":"2023","unstructured":"Farshadpour F, Taherkhani R, Shahabi A. High Prevalence of Occult Hepatitis B Virus Infection among Iranian Hemodialysis Patients. Am J Trop Med Hyg. 2023;108(5):1017\u201324.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"14010_CR12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/15321819.2022.2046602","volume":"43","author":"F Farshadpour","year":"2022","unstructured":"Farshadpour F, Taherkhani R, Shaeri M. Prevalence and risk factors of hepatitis E virus infection among patients with beta-thalassemia major in South of Iran. J Immunoass Immunochem. 2022;43(4):452\u201362.","journal-title":"J Immunoass Immunochem"},{"issue":"10","key":"14010_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/03913988211027177","volume":"44","author":"M Ouji","year":"2021","unstructured":"Ouji M, Taherkhani R, Farshadpour F. High prevalence of hepatitis E among regular hemodialysis patients in South of Iran. Int J Artif Organs. 2021;44(10):658\u201363.","journal-title":"Int J Artif Organs"},{"issue":"8","key":"14010_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/fvl-2018-0015","volume":"13","author":"M Azami","year":"2018","unstructured":"Azami M, Badfar GR, Esmaeli E, Moslemirad M, Rahmati S. Epidemiology of human T-lymphotropic virus type 1 among blood donors and general population in Iran: a meta-analysis. Future Virol. 2018;13(8):585\u201399.","journal-title":"Future Virol"},{"issue":"2","key":"14010_CR15","first-page":"161","volume":"6","author":"MR Pourkarim","year":"2004","unstructured":"Pourkarim MR, Khamisipour GHR, Zandi K, Roustaei MH. Prevalence of anti-HTLV-I&II antibodies in blood donors in Bushehr province. Iran South Med J. 2004;6(2):161\u20134.","journal-title":"Iran South Med J"},{"issue":"4","key":"14010_CR16","first-page":"99","volume":"2","author":"MR Pourkarim","year":"2005","unstructured":"Pourkarim MR, Khamisipour GR, Hajiani GR, Tahmasebi R, Ardeshirdavani N. Seroepidemiological investigation of HTLV I,II infection among Busherian multi-transfused patients in 2003. Bloodj. 2005;2(4):99\u2013104.","journal-title":"Bloodj"},{"issue":"43","key":"14010_CR17","first-page":"43","volume":"11","author":"A Moradi","year":"2003","unstructured":"Moradi A, Yaghoubnezhad Z, Mohagheghi A, Shahraki S, Borji A, Firouzkouhi M. Seroepidemiology Of HTLV-1 Antibody In The Thalassemic Patients In Zahedan And Zaboul Cities In 2001. J Adv Med Biomed Res. 2003;11(43):43\u20139.","journal-title":"J Adv Med Biomed Res"},{"key":"14010_CR18","unstructured":"Ardalan N, Abdi M, Rahimian, Zarif B, Amini A, Meamari F, Haydari E, Ahmadi A. Prevalence of human T-lymphotropic virus types I&II among high risk groups in Sanandaj in 2010. SJKU. 2013;18(2):51\u20137."},{"issue":"1","key":"14010_CR19","first-page":"169","volume":"4","author":"Z Mortezaie","year":"2012","unstructured":"Mortezaie Z, Bouzari M, Roghanian R. Evaluating the frequency of HTLV-\u0399\/II infection among blood donors, major thalassemic patients and individuals infected with hepatitis B and C viruses in Isfahan, Iran. IJBC. 2012;4(1):169\u201375.","journal-title":"IJBC"},{"key":"14010_CR20","unstructured":"Ghadiri K, Hashemian AH, Rezaei M, Payandeh M, Zare ME. Serologic prevalence of human T-lymphotropic virus (HTLV) among major thalassemic patients in Kermanshah 2010. Int J Hematol Oncol Stem Cell Res. 2011:14\u20137."},{"issue":"1","key":"14010_CR21","first-page":"1","volume":"1","author":"H Mansouritorghabeh","year":"2008","unstructured":"Mansouritorghabeh H, Badiei Z. Transfusion-transmitted viruses in individuals with \u03b2 thalassemia major at Northeastern Iran, a retrospective sero-epidemiological survey. IJBC. 2008;1(1):1\u20134.","journal-title":"IJBC"},{"issue":"47","key":"14010_CR22","first-page":"19","volume":"12","author":"G Anaraki Mohammadi","year":"2005","unstructured":"Anaraki Mohammadi G, Sadeghipour A, Vossough P, Nour Mohammadi I, Mirnateghi A. Assessment of the Prevalence of Human T-Lymphotropic Virus type 1 among Thalassemic Patients with Frequent Blood Transfusion in Tehran in 2003. RJMS. 2005;12(47):19\u201324.","journal-title":"RJMS"},{"issue":"1","key":"14010_CR23","first-page":"44","volume":"6","author":"A Karimi","year":"2006","unstructured":"Karimi A, Nafisi M. Seroprevalence of Human T-Cell Leukemia Virus Type-1 (HTLV-1) in High Risk Patients. J Res Health Sci. 2006;6(1):44\u20137.","journal-title":"J Res Health Sci"},{"key":"14010_CR24","doi-asserted-by":"crossref","unstructured":"Ghaffari J, Kowsarian M, Mahdavi MR, Vahid Shahi K, Rafatpanah H, Tafreshian AR. Prevalence of HTLV-I infection in patients with major Thalassemia in Mazandaran, North of Iran. Jundishapur J Microbiol. 2013;6(1):57\u201360.","DOI":"10.5812\/jjm.4702"},{"issue":"7","key":"14010_CR25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1089\/aid.2012.0382","volume":"29","author":"WM Switzer","year":"2013","unstructured":"Switzer WM, Shankar A, Trimble SR, Thompson AAGP, Cohen AR, Coates TD, Vichinsky E, Neufeld EJ. Boudreaux JM HW: Human T cell lymphotropic virus type 1 infection among US thalassemia patients. AIDS Res Hum Retroviruses. 2013;29(7):1006\u20139.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"14010_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1258\/095646206778145541","volume":"17","author":"PM Tseliou","year":"2006","unstructured":"Tseliou PM, Spanakis N, Spiliotakara A, Markogiannakis A, Legakis NJ, Tsakris A. Prevalence of infection by HTLV-I\/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece. Int J STD AIDS. 2006;17(8):543\u20136.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"14010_CR27","first-page":"e85164","volume":"6","author":"MR Hedayati-Moghaddam","year":"2019","unstructured":"Hedayati-Moghaddam MR, Fathimoghadam F, Soghandi L, Darrudi A. High prevalence of HTLV-1 infection among hemodialysis patients in Neyshabur, northeast of Iran. Int J Infect. 2019;6(1):e85164.","journal-title":"Int J Infect"},{"issue":"1","key":"14010_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.47723\/vp5phb46","volume":"21","author":"Z Al-jubouri","year":"2025","unstructured":"Al-jubouri Z, Abdullah SF. Active Human T- lymphotropic Virus Type-1 Antigenemia in a Sample of Iraqi Patients on Maintenance Hemodialysis. Al-Kindy Col Med J. 2025;21(1):58\u201364.","journal-title":"Al-Kindy Col Med J"},{"issue":"1","key":"14010_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12882-017-0484-y","volume":"18","author":"RF Santos","year":"2017","unstructured":"Santos RF, Concei\u00e7\u00e3o GC, Martins MS, Kraychete A, Penalva MA, Carvalho EM, Lopes AA, Rocha PN. Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients. BMC Nephrol. 2017;18(1):64.","journal-title":"BMC Nephrol"},{"issue":"1","key":"14010_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1492-7535.2004.0085bh.x","volume":"8","author":"I Stefanidis","year":"2004","unstructured":"Stefanidis I, Zervou Ek, Rizos C, Liaskos C, Zarogiannis S, Liakopoulos V, Kyriakopoulos G, Dalekos G. Prevalence of Hepatitis (A\u2013E) and HTLV-I\/II Infection Markers in Hemodialysis Patients of Central Greece. Hemodial Int. 2004;8(1):101\u2013101.","journal-title":"Hemodial Int"},{"issue":"4","key":"14010_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/tme.12133","volume":"24","author":"M Keshvari","year":"2014","unstructured":"Keshvari M, Hajibeigi B, Azarkeivan A, Keyvani H, Behnava B, Saiedi Hosseini S, Sharafi H, Alavian S. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients. Transfus Med. 2014;24(4):227\u201332.","journal-title":"Transfus Med"},{"key":"14010_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2017.03.010","volume":"58","author":"I Marr","year":"2017","unstructured":"Marr I, Davies J, Baird RW. Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia. Int J Infect Dis. 2017;58:90\u20135.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-14010-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-14010-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:26:44Z","timestamp":1791336404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-14010-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14010"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-14010-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethical Committee of Bushehr University of Medical Sciences with reference numbers IR.BPUMS.REC.1401.019 and R.BPUMS.REC.1401.020. All participants gave written informed consent to use their data and blood samples for analysis and detection of HTLV infection. The study followed the relevant guidelines and regulations. All methods were performed under the relevant guidelines and regulations in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants gave written informed consent to publish their data in a journal article.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1780"}}